The development of a plant-based vaccine for measles
Identifieur interne : 004331 ( PascalFrancis/Checkpoint ); précédent : 004330; suivant : 004332The development of a plant-based vaccine for measles
Auteurs : D. E. Webster [Australie] ; M. C. Thomas [Australie] ; Z. Huang [Australie] ; S. L. Wesselingh [Australie]Source :
- Vaccine [ 0264-410X ] ; 2005.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Vaccin, Vaccination.
English descriptors
- KwdEn :
Abstract
Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:06-0198087Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The development of a plant-based vaccine for measles</title>
<author><name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The The Baker Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0198087</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0198087 INIST</idno>
<idno type="RBID">Pascal:06-0198087</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004452</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C43</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">004331</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004331</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The development of a plant-based vaccine for measles</title>
<author><name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>The The Baker Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic. 3001</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Melbourne, Vic</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Measles</term>
<term>Vaccination</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Vaccin</term>
<term>Vaccination</term>
<term>Rougeole</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term>
<term>Vaccination</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0264-410X</s0>
</fA01>
<fA02 i1="01"><s0>VACCDE</s0>
</fA02>
<fA03 i2="1"><s0>Vaccine</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>15</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>The development of a plant-based vaccine for measles</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Plant-derived vaccines and antibodies: Potential and limitations</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>WEBSTER (D. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>THOMAS (M. C.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HUANG (Z.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>WESSELINGH (S. L.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>ARNTZEN (Charles)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>DODET (Betty)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>HAMMOND (Rose)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>KARASEV (Alexander)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1"><s1>RUSSELL (Michael)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="06" i2="1"><s1>PLOTKIN (Stanley)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Children's Vaccines Group, MacFarlane Burnet Institute for Medical Research and Public Health, P.O. Box 2284</s1>
<s2>Melbourne, Vic. 3001</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>School of Biological Sciences, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>The The Baker Medical Research Institute</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Medicine, Monash University</s1>
<s2>Melbourne, Vic</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Arizona State University</s1>
<s2>Tempe</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>University of Pennsylvania, Philadelphia</s1>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Dodet Bioscience, 66 cours Charlemagne</s1>
<s2>69002 Lyon</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>Fondation Mérieux</s1>
<s2>69002 Lyon</s2>
<s3>FRA</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>1859-1865</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20289</s2>
<s5>354000133094310200</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0198087</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Vaccine</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Plant-based vaccination strategies have the potential to overcome the limitations of the current measles vaccine. The measles virus hemagglutinin (MV-H) protein has been expressed in tobacco. Oral immunisation of mice with plant-derived MV-H protein resulted in MV-specific antibodies and secretory IgA, indicative of humoral and mucosal immune responses. In addition, boosting with oral plant-derived MV-H protein following a MV-H DNA prime, resulted in a greater response than could be induced with either vaccine alone. Collectively, this research represents a significant step towards an effective oral measles vaccine that would be temperature-stable, easy to administer and amenable to inexpensive manufacture.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05F04</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Vaccin</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Vaccine</s0>
<s5>05</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Vacuna</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Vaccination</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Vaccination</s0>
<s5>06</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Vacunación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Rougeole</s0>
<s5>14</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Measles</s0>
<s5>14</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sarampión</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fN21><s1>121</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Plant-derived vaccines and antibodies: Potential and limitations. Meeting</s1>
<s3>Veyrier-du-Lac FRA</s3>
<s4>2004-03-21</s4>
</fA30>
</pR>
</standard>
</inist>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
</noRegion>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<name sortKey="Huang, Z" sort="Huang, Z" uniqKey="Huang Z" first="Z." last="Huang">Z. Huang</name>
<name sortKey="Thomas, M C" sort="Thomas, M C" uniqKey="Thomas M" first="M. C." last="Thomas">M. C. Thomas</name>
<name sortKey="Webster, D E" sort="Webster, D E" uniqKey="Webster D" first="D. E." last="Webster">D. E. Webster</name>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
<name sortKey="Wesselingh, S L" sort="Wesselingh, S L" uniqKey="Wesselingh S" first="S. L." last="Wesselingh">S. L. Wesselingh</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004331 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 004331 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:06-0198087 |texte= The development of a plant-based vaccine for measles }}
This area was generated with Dilib version V0.6.33. |